Our analysis paints an alarming picture:

Despite good intentions and promising strategies, Canada’s immunization efforts ultimately fall short – Leaving our most vulnerable at risk.

The 2022-2023 vaccine report card paints a grim picture, raising difficult questions about the nation’s preparedness to tackle ongoing and upcoming health crises, despite 3 years of COVID19 highlighting the foundational importance of vaccines to individuals, public health and the economy.

This third annual report once again gives Canada a failing grade on vaccines. This is shocking considering the overwhelming evidence that vaccines are effective, affordable and keep the country safe. The report also highlights that Canada is actually moving backwards in immunization compared to OECD countries.

Become a free member

Key Takeaways

The national average is an F.
No province got higher than a “D” on the report card for adult vaccinations.
Nova Scotia makes good on its promise to fund the quadrivalent high-dose flu vaccine for its seniors; a significant portion of its the province’s population.
Quebec now covers the Shingles vaccine, but only for people 80+, rather than 50+ or even 65+. Average age of death in Quebec is 83.
CanAge urges replacing older and less effective pneumonia vaccines with the new best-in-class PCV-20, especially for vulnerable seniors and in long-term care.
Canada needs a comprehensive strategy for shingles and pneumonia vaccines, adopting best-in-class solutions and latest recommendations and to prepare for the now approved RSV vaccine for seniors, under review by NACI now.
CanAge continues its advocacy for a more strategic, inclusive, and effective approach to immunization for seniors to improve quality of life and reduce the burden on the health care system.